SRXH news

SRX Global Inc. announced fiscal Q3 2026 results with improved adjusted EBITDA and a 10-for-1 stock split filing. The company declared a one-time cash dividend of $0.05 per share and approved a stock repurchase program.

The company resolved its continued listing deficiencies under Section 1003 to end a compliance investigation. This reinstates full status with NYSE American and removes the technical compliance indicator.

SRX Global reported its EMJX crypto strategy generated 25% returns since February 2026, outperforming Bitcoin by roughly 30 points. The company plans to transition the strategy from paper to live trading as market signals shift to Mixed.

SRX Global approved a one-time dividend paid from SpaceX profits. This payout highlights strong performance across their investment portfolio.

SRX Global announced a 60-to-1 share consolidation effective July 6, 2026, to comply with NYSE American listing requirements. This reverse split, which combines every 60 existing shares into one, is typically viewed by the market as a distress signal aimed at elevating the stock price.

SRx Health Solutions completed its acquisition of EMJ Crypto Technologies and rebranded to SRX Global, launching an AI-driven capital allocation platform focused on high-conviction investments. The combined company will leverage proprietary algorithms for digital and traditional asset management whi…